CAS NO: | 102625-70-7 |
生物活性 | Pantoprazole (BY10232) is an orally active and potentproton pumpinhibitor (PPI)[1]. Pantoprazole, a substituted benzimidazole, is a potentH+/K+-ATPaseinhibitor with anIC50of 6.8 μM. Pantoprazole improves pH stability and has anti-secretory, anti-ulcer activities. Pantoprazole significantly increased tumor growth delay combined with Doxorubicin (HY-15142)[3][4]. | ||||||||
IC50& Target | proton pump | ||||||||
体外研究 (In Vitro) | Pantoprazole (BY1023; 1-10000 μM) leads to concentration-dependent increases in endosomal pH in EMT-6 and MCF7 cells[1]. | ||||||||
体内研究 (In Vivo) | Pantoprazole (BY1023; 200 mg/kg; IP; once a week for 3 weeks) significantly increases tumor growth delay of MCF-7 xenografts combined with Doxorubicin[1].
| ||||||||
Clinical Trial | |||||||||
分子量 | 383.37 | ||||||||
Formula | C16H15F2N3O4S | ||||||||
CAS 号 | 102625-70-7 | ||||||||
中文名称 | 泮托拉唑 | ||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |